Alzheimer Disease
1,735
314
402
848
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
246 trials with published results (14%)
Research Maturity
848 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.9%
119 terminated out of 1735 trials
87.7%
+1.2% vs benchmark
9%
148 trials in Phase 3/4
29%
246 of 848 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 848 completed trials
Clinical Trials (1735)
Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
Music for Pain and Dementia
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals
Olfactory Biopsies
Virtual Reality Cognitive Stimulation for Alzheimer's
Cholinergic Health After Menopause (CHAMP)
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Silkworm Pupa Powder Improves Alzheimer's Disease
German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Efficacy of Caregiver Training Program in Enhancing Caregiver and Patient Outcomes
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
Rapamycin - Effects on Alzheimer's and Cognitive Health
F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)
Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-Fluselenamyl
Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease